The predictive and prognostic value of CMPK1 mRNA expression and genetic polymorphisms have been described in colorectal tumors8, non-small cell lung carcinoma9, and pancreatic cancer patients who received pyrimidine nucleoside analogue-based chemotherapies as first line treatment10. The gene discussed is CMPK1; the disease is familial pancreatic carcinoma.